These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1576322

  • 21. Microscale production of hybridomas by hypo-osmolar electrofusion.
    Zimmermann U, Klöck G, Gessner P, Sammons DW, Neil GA.
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):14-8. PubMed ID: 1576318
    [Abstract] [Full Text] [Related]

  • 22. Establishment of a human fusion partner for making human T-T hybridomas which can grow in serum free medium.
    Kawahara H, Maeda-Yamamoto M, Hakamata K.
    Hum Antibodies; 1999 Jan; 9(2):83-7. PubMed ID: 10405828
    [Abstract] [Full Text] [Related]

  • 23. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T, Chiba J, Ohnishi K.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [Abstract] [Full Text] [Related]

  • 24. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M, Sasamori E, Chiba T, Hanyu Y.
    J Immunol Methods; 2011 Oct 28; 373(1-2):102-10. PubMed ID: 21878337
    [Abstract] [Full Text] [Related]

  • 25. Occurrence of hybridomas producing multispecific IgM in human x (human-mouse) fusions with lymphocytes from different human immune compartments.
    Jahn S, Schwab J, Kiessig ST, Lukowsky A, Huhnholtz K, Mehl M, Specht U, Grunow R, von Baehr R.
    Allerg Immunol (Leipz); 1989 Oct 28; 35(4):271-7. PubMed ID: 2624250
    [Abstract] [Full Text] [Related]

  • 26. Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1.
    Clark EA, Grabstein KH, Gown AM, Skelly M, Kaisho T, Hirano T, Shu GL.
    J Immunol; 1995 Jul 15; 155(2):545-55. PubMed ID: 7608535
    [Abstract] [Full Text] [Related]

  • 27. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B, Jondal M, Sundqvist VA.
    Hum Antibodies Hybridomas; 1991 Jan 15; 2(1):26-32. PubMed ID: 1651784
    [Abstract] [Full Text] [Related]

  • 28. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
    Power DA, Gerkis V, d'Apice AJ.
    Hum Antibodies Hybridomas; 1990 Jan 15; 1(1):34-41. PubMed ID: 2103351
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. On chip electrofusion of single human B cells and mouse myeloma cells for efficient hybridoma generation.
    Kemna EW, Wolbers F, Vermes I, van den Berg A.
    Electrophoresis; 2011 Nov 15; 32(22):3138-46. PubMed ID: 22025094
    [Abstract] [Full Text] [Related]

  • 32. Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
    Greenlee AR, Magnuson NS, Smith C, Butt BM, McKiernan AJ, Davis WC.
    Vet Immunol Immunopathol; 1990 Nov 15; 26(3):267-83. PubMed ID: 2264287
    [Abstract] [Full Text] [Related]

  • 33. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M, Jahn S, Schwab J, Döcke W, Volk HD, von Baehr R.
    Hum Antibodies Hybridomas; 1992 Apr 15; 3(2):86-92. PubMed ID: 1633269
    [Abstract] [Full Text] [Related]

  • 34. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
    Gruber MF, Bjorndahl JM, Nakamura S, Fu SM.
    J Immunol; 1989 Jun 15; 142(12):4144-52. PubMed ID: 2470814
    [Abstract] [Full Text] [Related]

  • 35. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG, Knost JA, Clarke G, Wilburn S, Oldham RK, Foon KA.
    J Immunol; 1983 Sep 15; 131(3):1201-4. PubMed ID: 6350451
    [Abstract] [Full Text] [Related]

  • 36. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T, Kato K, Shiku H, Yamada K.
    Gan To Kagaku Ryoho; 1983 Dec 15; 10(12):2575-81. PubMed ID: 6606396
    [Abstract] [Full Text] [Related]

  • 37. Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells.
    Trontelj K, Rebersek M, Kanduser M, Serbec VC, Sprohar M, Miklavcic D.
    Bioelectrochemistry; 2008 Nov 15; 74(1):124-9. PubMed ID: 18667367
    [Abstract] [Full Text] [Related]

  • 38. Hybridomas secreting monoclonal antibody with specificity for Toxoplasma gondii.
    Sethi KK, Endo T, Brandis H.
    J Parasitol; 1980 Apr 15; 66(2):192-6. PubMed ID: 7391860
    [Abstract] [Full Text] [Related]

  • 39. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
    Gravekamp C, Santoli D, Vreugdenhil R, Collard JG, Bolhuis RL.
    Hybridoma; 1987 Apr 15; 6(2):121-33. PubMed ID: 3494659
    [Abstract] [Full Text] [Related]

  • 40. Analysis of the human tonsil B cell repertoire by somatic hybridization: occurrence of both "monospecific" and "multispecific" (auto)antibody-secreting cells.
    Logtenberg T, Kroon A, Gmelig-Meyling FH, Ballieux RE.
    Eur J Immunol; 1987 Jun 15; 17(6):855-9. PubMed ID: 3496225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.